Ouro Medicines
Ouro Medicines is dedicated to developing immune reset therapeutics for people living with chronic immune-mediated diseases. Our approach is focused on leveraging T cell engagers in B cell mediated diseases to achieve immune resets that enable durable remissions without ongoing immunosuppression for patients. Based in San Francisco, Ouro was founded by Monograph Capital in partnership with GSK. We are also backed by leading investors TPG, NEA, Norwest and more.
7-day free trial · no credit card
Verified contacts
16
available on Kipplo
LinkedIn employees
25
11 to 50 range
Open roles
—
no listings
Distinct roles
8
indexed titles
Tech stack
1
tools in use
Monthly traffic
—
organic / mo
Sign up free to see all 16 verified contacts at Ouro Medicines
Free for 7 days · 50 credits · no card · only pay for verified records.
Decision-makers and verified team members
16 contacts with verified email or phone · masked until revealed.
- CZ
Charlie Zhou
Head of Portfolio Strategy · Finance & Accounting
EmailPhone - DC
David Chau
Head of Technical Operations · Operations
EmailPhone - RD
Racquel Domingo-Gonzalez
Senior Scientist · Research & Development
EmailPhone - CC
Christina Carlson
General Counsel and Chief Operating Officer · Legal
EmailPhone
Showing 4 of 16 verified contacts
Top roles at Ouro Medicines
8 distinct titles indexed · top 8 shown.
- 1associate director, cmc analytical development
- 1executive business partner
- 1general counsel and chief operating officer
- 1head of portfolio strategy
- 1head of technical operations
- 1senior research consultant oncology & immunotherapy
- 1senior scientist
- 1vice president, clinical operations
Sign up to unlock all 16 contacts at Ouro Medicines
Free for 7 days · 50 credits · no card · only pay for verified records.
Sign up to reveal 16 verified contacts at Ouro Medicines
7-day trial · no credit card · cancel anytime · only pay for verified records.
Trusted by sales, marketing, and GTM engineering teams.